Science Milestone: Driving T cell therapy

The pioneering immunology discoveries that birthed CAR T cell therapy and reshaped the battle against cancer. 

A decade ago, two patients received an innovative therapy for leukemia that revolutionized immunotherapy research. Today, chimeric antigen receptor (CAR) T cell therapy continues to evolve with advances in T cell and receptor engineering as a promising treatment for blood malignancies, solid tumors, and autoimmune diseases.  

Explore this milestone article from Drug Discovery News to learn how scientists harnessed the body's defenses to develop CAR T cell therapy.